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Emerging evidence suggests that supernumerary centrosomes drive genome instability 
and is linked to oncogenesis1-3. Human T-cell leukemia virus type I (HTLV-I) is 
etiologically associated with adult T-cell leukemia (ATL)4. ATL cells are aneuploid, but 
the causes of aneuploidy are incompletely understood5,6. Here we showed that 
centrosome amplification is frequent in HTLV-I-transformed cells and that this 
phenotype is caused by the viral Tax oncoprotein. We also found that the fraction of Tax 
protein which localizes to centrosomes interacts with TAX1BP2, a novel centrosomal 
protein composed almost entirely of coiled-coil domains. Overexpression of TAX1BP2 
inhibited centrosome duplication, whereas depletion of TAX1BP2 by RNAi resulted in 
centrosome hyperamplification. Our findings suggest that HTLV-I Tax oncoprotein 
targets a novel centrosomal protein, TAX1BP2, to create genomic instability and 
aneuploidy.   
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The centrosome is a major microtubule-organizing center that governs spindle assembly 
and bipolarity7. During the cell cycle it duplicates only once and undergoes characteristic 
changes. Impairment of the centrosome cycle may lead to chromosome missegregation 
and aneuploidy1. Indeed, centrosome abnormalities are frequent in various malignant 
tumors including chronic myeloid leukemia3. However, the role of centrosome disorder 
in adult T-cell leukemia (ATL), a fetal disease induced by a human retrovirus4, is not 
known. 
ATL is caused by human T-cell leukemia virus type I (HTLV-I)4. Over 20 million 
individuals globally are infected with HTLV-I. This virus-induced leukemogenesis 
occurs in 2-5% of individuals over a latency period of more than 20 years6. Plausibly, for 
the infected cells to acquire selective growth advantages, HTLV-I has to initiate the 
disruption of several cellular events and surveillance mechanisms. How this occurs is not 
well understood; however, an HTLV-I-encoded oncoprotein, Tax, has been implicated in 
the immortalization and transformation of CD4+ T-lymphocytes8. Tax is a transcriptional 
activator that has profound impact on cell signaling through the CRE, κB and SRE 
pathways and on the expression of various cytokines and proto-oncogenes5,8. In addition, 
Tax has also been shown to induce genome instability by disrupting several cell cycle 
checkpoints5,10 leading to the accumulation of damaged cellular DNA11.  For its various 
manifestations, current evidence indicates that Tax directly binds several discrete cellular 
proteins5,8.         
In viral transformation of cells, human papillomaviruses and hepatitis B virus induce 
centrosome pathology12,13. To ask if HTLV-I shares this aspect of oncogenesis, we 
investigated whether centrosomal abnormalities also occur in ATL cells. We visualized 
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centrosomes in control Jurkat cells and two HTLV-I+ ATL cell lines (MT4 and C8166-
45) using anti-γ-tubulin antibody and quantified cells that had more than 2 centrosomes 
(Fig. 1a, b). Whereas <5% of Jurkat cells had supernumerary centrosomes, the 
percentages of MT4 and C8166-45 cells with >2 centrosomes were significantly higher 
(~ 30%; see Fig. 1a, panel 2 for an example of MT4 cell with a cluster of centrosomes). 
These results provide the first evidence for centrosome amplification in ATL cells. We 
next asked whether the HTLV-1 Tax oncoprotein is causal for centrosome amplification. 
To address this question, we assayed centrosome duplication in a JPX9 cell line which 
carries a Tax gene driven by the inducible metallothionein promoter10. JPX9 cells not 
induced for Tax showed cells with >2 centrosomes at a prevalence comparable to Jurkat 
cells (Fig. 1b, compare column 4 to 1). By contrast, induction of Tax expression in JPX9 
cells led to a distinct increase in cells with supernumerary centrosomes (Fig. 1b, compare 
column 5 to 4). These results correlate Tax expression with centrosome amplification in 
T cells. 
Because Jurkat, MT4 and C8166-45 leukemic cells might already have other hidden 
defects in cell cycle and growth control that contribute to the centrosome abnormalities 
induced by Tax, we sought to analyze centrosome duplication in IMR-90 primary human 
fibroblasts derived from normal fetal lung. Expression of Tax resulted in centrosome 
amplification in ~30% of IMR-90 cells (Fig. 1b, compare column 7 to 6). Moreover, the 
supernumerary centrosomes in Tax-expressing IMR-90 cells contained centrobin (Fig. 
1b, inset), a recently-identified coiled-coil protein preferentially associated with daughter 
centroles14. Thus, Tax alone is sufficient to induce centrosome duplication errors in 
normal human cells. 
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To understand better the mechanism of Tax’s effect on centrosomes, we performed 
overexpression assays in CHO cells. We used hydroxyurea (HU) to inhibit cellular DNA 
synthesis and uncouple centrosome duplication from DNA replication and cytokinesis, 
allowing for multiple rounds of centrosome duplication to occur within the cell15. We 
also employed the overexpression of Cdk2 and an Rb mutant lacking the Cdk 
phosphorylation sites (Rb∆Cdk). Cdk2 is a well-known stimulator of centrosome 
duplication15-17, and Rb∆Cdk has been found to inhibit this process15. We found that 
Cdk2 and Rb∆Cdk behaved in our assays as positive and negative regulators of 
centrosome duplication, respectively. We further observed that Tax stimulated 
centrosome duplication as effectively as Cdk2 (Fig. 1c, panel 2 compared to panel 1; and 
Fig. 1d, column 5 compared to columns 3 and 4). This is generally consistent with recent 
findings from another group18.   
Tax localizes predominantly to nuclear and perinuclear speckles10,11; and this staining 
pattern is compatible with a fraction of Tax localizing to centrosomes. To shed light on 
how Tax might stimulate centrosome duplication, we investigated whether it could be 
found at centrosomes. We stained Tax-expressing HeLa cells simultaneously with anti-
Tax and anti-pericentrin. We saw that while the majority of Tax was in the nucleus, a 
portion of Tax costained with pericentrin (Fig. 1e). To confirm this colocalization, we 
next immunoprecipitated extracts of HTLV-I-transformed MT4 cells with monoclonal 
anti-γ-tubulin antibody and queried by Western blotting for Tax in the 
immunoprecipitate. Tax did co-precipitate with γ-tubulin, an integral constituent of 
centrosomes, but it did not precipitate with material recovered using control irrelevant 
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mouse IgG (Fig. 1f, lane 2 compared to lane 1).  Taken together, the results support the 
presence of Tax at cellular centrosomes.    
What component of the centrosome might Tax recognize? We had previously shown 
using yeast two-hybrid assay that Tax recognizes and interacts with several mammalian 
coiled-coil proteins19. These coiled-coil Tax-binding proteins include human mitotic 
checkpoint protein MAD110, IκB kinase regulatory subunit IKKγ20, and another highly 
coiled-coil protein which we named TAX1BP2/TXBP121. TAX1BP2 has heretofore not 
been characterized but shares significant homology with centrosomal protein C-Nap121. 
We hypothesized that TAX1BP2 might be a centrosome constituent that tethers Tax to 
this organelle. 
To confirm the interaction between TAX1BP2 and Tax, we raised rabbit polyclonal 
antisera against two synthetic TAX1BP2 peptides. The reactivity and specificity of these 
antibodies were verified by Western blotting and immunofluorescence (see examples in 
Fig. 2f). Using these antibodies and a monoclonal anti-Tax antibody, we assessed further 
the interaction between Tax and TAX1BP2 in cultured HeLa cells by reciprocal 
immunoprecipitations followed with immunoblotting. Hence, TAX1BP2 was detected in 
anti-Tax immunoprecipitates (Fig. 2a), and Tax in anti-TAX1BP2 precipitates (Fig. 2b). 
Next, we employed 7 TAX1BP2 mutants to map the Tax-binding domain in TAX1BP2 to 
amino acids 1109-1162 which contain a leucine zipper with four periodically spaced 
leucines. We noted that this Tax-binding domain is not conserved in TAX1BP2-
homologous centrosomal protein C-Nap1. When we mutated the leucine motif by 
replacing the second or the third leucine with proline, binding of Tax by TAX1BP2 was 
lost (Fig. 2c; mutants M5’ and M5’’ compared to M5). The interaction between Tax and 
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TAX1BP2-M5 (region 1109-1162) was also verified using GST pull-downs. We 
observed that recombinant His-Tax bound to GST-TAX1BP2 and GST-TAX1BP2-M5, 
but not to GST (Fig. 2d, compare lanes 2 and 3 to lane 1). In addition, we demonstrated 
the co-immunoprecipitation of Tax and TAX1BP2 from extracts of HTLV-I-transformed 
MT4 cells (Fig. 2e). Finally, inside intact HeLa and MT4 cells, Tax colocalized with 
TAX1BP2 at perinuclear dots expected for centrosomes (Fig. 2f).  
A TAX1BP2-related protein is the 220-kD CROCC protein which is the structural 
component of ciliary rootlet22,23. The mRNA of CROCC/rootletin shares a common 3’ 
portion of the TAX1BP2 transcript (Fig. S1a). Further comparison of the two sequences 
revealed that TAX1BP2 and CROCC are alternatively spliced isoforms, likely 
transcribed from two different promoters. The retention of the 1.5-kb intron 5 in 
TAX1BP2 leads to an alternate translational start site. CROCC is expressed abundantly 
in retina and sparsely in brain, trachea and kidney22. Consistent with this, we did not 
detect CROCC transcript in any of the human tissues and cells tested (data not shown). In 
contrast, we detected the specific expression of TAX1BP2 mRNA in various tissues and 
cells (Fig. S1b-d), and an ~150-kD TAX1BP2 protein was easily detected in HeLa cells 
(Fig. S1e).       
TAX1BP2 is highly homologous to centrosomal protein C-Nap121, and the staining 
pattern of TAX1BP2 (Fig. 2f) is generally compatible with that of centrosome. Next, we 
directly confirmed that TAX1BP2 was present at centrosomes by demonstrating co-
localization of cell endogenous TAX1BP2 (Fig. 3a) and exogenously overexpressed HA-
tagged TAX1BP2 (Fig. 3b) with γ-tubulin and pericentrin (data not shown).  Further, we 
characterized in TAX1BP2 two separate centrosome-targeting domains corresponding to 
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amino acids 1-941 (truncated mutant M6) and 1040-1313 (mutant M7) (Fig. 3c, d). These 
domains when fused to GFP are sufficient to target the heterologous GFP protein to the 
centrosome (Fig. 3d and data not shown). Co-immunoprecipitation experiment also 
verified that the GFP-TAX1BP2-M7 protein was in a protein complex containing γ-
tubulin (Fig. 3f). Interestingly, the centrosomal localization of TAX1BP2 is independent 
of the integrity of microtubules, because treatment with either microtubule-polymerizing 
agent taxol (Fig. 3e) or microtubule-disrupting agent nocodazole (data not shown) did not 
perturb its localization.        
The centrosomal localization of TAX1BP2 (Fig. 3), its interaction with Tax (Fig. 2), 
and the induction by Tax of supernumerary centrosomes (Fig. 1) prompted us to consider 
a role for TAX1BP2 in governing centrosome duplication. To test this hypothesis, we 
overexpressed TAX1BP2 in CHO cells and assessed centrosome duplication. 
Intriguingly, the number of cells with supernumerary centrosomes in TAX1BP2-
overexpressing cells was significantly lower than in either control cells or cells 
overexpressing Cdk2 (Fig. 4a). This apparent inhibitory effect of TAX1BP2 is 
comparable to the repression of centrosome duplication previously reported for 
Rb∆Cdk15. The inhibition was specifically induced by TAX1BP2 and was not observed 
with TAX1BP2-homologous centrosomal protein C-Nap121, Tax-binding cell cycle 
regulatory protein MAD120, or a dominant inactive mutant of MAD120 (MAD1M4; Fig. 
4a, columns 6-9 compared to column 5). Because the phenotype based on overexpression 
of transfected TAX1BP2 cannot formally comment on the role of cell endogenous 
TAX1BP2, we next performed knock-down experiments. We designed two small hairpin 
RNAs (shRNAs; shBP2a and shBP2b) targeting coding sequences of TAX1BP2 
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transcript and transfected them into CHO cells. While shBP2a was more effective in 
depleting TAX1BP2, both shRNAs showed suppressive activities (Fig. 4b, lanes 2, 3, 5 
and 6 compared to lane 1). When separately expressed, both shBP2a and shBP2b 
moderately enhanced the number of cells with supernumerary centrosomes (Fig. 4c, 
columns 4 and 5 compared to column 2), suggesting that the depletion of endogenous 
TAX1BP2 removed a negative effect on centrosome duplication. In keeping with the 
concept that Tax might function through inhibition of TAX1BP2, expression of Tax did 
not further stimulate centrosome amplification in TAX1BP2-depleted cells (Fig. 4c, 
column 6 compared to column 4). When we omitted treatment of cells with HU and 
propagated cells after transfection for 72 h, the effects of TAX1BP2 knock-down became 
more evident. Thus, the percentage of shRNA-transfected cells with increased 
centrosomes became significantly higher than those from control GFP- and TAX1BP2-
expressing cells not treated with HU (Fig. 4d, columns 4 and 5 compared to columns 1 
and 2; and Fig. S2, panels 6 and 9 compared to panel 3). Again, while Tax sufficiently 
induced centrosome duplication in CHO cells, Tax could not further enhance the effect 
induced by depletion of TAX1BP2 (Fig. 4d, column 6 compared to columns 3 and 4). 
Altogether, the results from both exogenous overexpressions and endogenous knock-
downs support a repressive role for TAX1BP2 in centrosome duplication, which is likely 
targeted by Tax. 
Above data show that Tax and TAX1BP2 have opposing effects on centrosome 
duplication. We next formally addressed if TAX1BP2 is the centrosomal protein targeted 
through direct protein-protein binding by Tax. If this reasoning is correct, then one 
prediction is that overexpression of TAX1BP2 should blunt Tax’s capacity to induce 
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supernumerary centrosomes. We found that TAX1BP2 did effect a dose-dependent 
reduction in the number of Tax-expressing cells with amplified centrosomes (Fig. 5a, 
columns 5 and 6 compared to column 4). Conversely, increased overexpression of Tax 
overcame the block to centrosome amplification by TAX1BP2 (Fig. 5a, columns 7 and 8 
compared to column 3). In contrast, coexpression with TAX1BP2 of a Tax point mutant 
(S132A) lacking the ability to interact with TAX1BP219 had no influence on the 
inhibition of centrosome duplication (Fig. 5, column 9 compared to column 3).  
We next assessed the centrosome phenotype of this Tax mutant and found that it was 
able to activate the HTLV-I LTR in a manner comparable to wild type Tax (Fig. 5b, 
column 3 compared to column 2), but it was no longer able to induce the centrosome 
amplification seen with wild type Tax (Fig. 5c, column 4 compared to columns 2 and 3). 
Thus, the interaction with TAX1BP2 correlates with Tax induction of centrosome 
overduplication. Importantly, this Tax mutant also lost the ability to transform rat 
embryonic fibroblasts (Fig. 5d) or to induce micronuclei formation (Fig. 5e), a marker for 
genome instability caused by the expression of Tax24. Mechanisms by which Tax induces 
transformation and genome instability are complex5,8. The correlation of Tax-TAX1BP2 
interaction with cellular transformation and genome instability does not exclude the 
involvement of other Tax-binding proteins. However, one interpretation to our findings is 
that the interaction with TAX1BP2 might serve one contributory role in these processes.  
On the other hand, we noted that a TAX1BP2 mutant (M6) which was fully 
repressive for centrosome duplication (Fig. 5f, column 4 compared to column 3) but does 
not contain the Tax-binding domain (Fig. 2c), was unable to rescue fully the phenotype of 
Tax (Fig. 5f, column 7 compared to column 6). Likewise, another TAX1BP2 mutant 
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(M4) defective in centrosomal targeting had no influence on the stimulatory effect of Tax 
(Fig. 5f, column 9 compared to column 5). Collectively, these results are consistent with 
the disruptive effect of Tax on centrosome amplification being mediated through direct 
protein-protein binding to TAX1BP2. What currently remains unanswered and needs 
further investigation is the mechanism for the repressive effect of TAX1BP2 on 
centrosome duplication.   
Here, we report on the finding of frequent amplification of centrosomes in cells 
expressing the HTLV-I Tax oncoprotein (Fig. 1). We suggest that Tax induces excessive 
centrosome duplication (Fig. 5) by targeting a hitherto novel centrosomal protein 
TAX1BP2 (Fig. 2 and Fig. 5).  Our evidence supports that TAX1BP2 may function to 
block centrosome reduplication (Fig. 3 and Fig. 4). Unlike centriolin and other 
centrosomal proteins that are also required for cytokinesis25, TAX1BP2 was not found in 
the midbody and depletion of TAX1BP2 did not lead to the formation of multinuclear  
syncytia (Fig. 4). Based on sequence homology and similarity in staining patterns, 
TAX1BP2 is more closely related to centrosomal coiled-coil proteins that include C-
Nap121, CEP110 and ninein26. C-Nap1 is the substrate of Nek2 kinase, a key regulator of 
centrosome structure and function21. On the other hand, Cdk2 kinase has been shown to 
regulate centrosome duplication partly through phosphorylation of nucleophosmin27. 
Thus, it will be of interest to investigate whether TAX1BP2 is phosphorylated by Nek2 
or Cdk2. In this regard, one recent study has demonstrated the centrosomal localization 
and function of CROCC as well as the phosphorylation of CROCC by Nek228. In 
addition, an interaction between CROCC and C-Nap1 has also been shown with yeast 
two-hybrid assay28. While we were able to detect, by co-immunoprecipitation and yeast 
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two-hybrid analysis, the homodimerization of TAX1BP2 (Fig. S3) and the interaction 
between TAX1BP2 and C-Nap1 (data not shown), the modification of TAX1BP2 was not 
seen in HeLa cells transfected with active Nek2 (Fig. S4a, lane 3 compared to lane 2). 
Neither could we observe the phosphorylation of TAX1BP2 by Nek2 in vitro (data not 
shown). In contrast, we detected Cdk2 phosphorylation of TAX1BP2 both in Cdk2-
overexpressing cells (Fig. S4b) and by in vitro kinase assay (Fig. S4c).  
Because the molecular mechanisms through which centrosome duplication is 
regulated are not well understood, it may be that TAX1BP2 is a component of the 
previously identified centrosome-intrinsic machinery that blocks reduplication29. In line 
with this hypothesis, the phosphorylation of TAX1BP2 by Cdk2 (Fig. S4) suggests that 
TAX1BP2 activity is regulated in a cell cycle-specific manner. Future analysis of how 
TAX1BP2 prevents centrosome overduplication and how Tax interferes with this 
function will reveal new aspects to the cellular control of genome stability and viral 
strategies to subvert this control.   
Whether centrosome abnormalities are the cause or consequence of tumor initiation 
and progression remains hotly debated3,30. HTLV-1 Tax is a well-studied transforming 
protein5,8. Our finding that Tax targets a centrosomal component to subvert cellular 
control of centrosome replication supports the notion that disordered centrosome 
amplification has a contributory role in driving tumorigenesis. Data here are consistent 
with previous findings from human papillomaviruses12 and hepatitis B virus13 and 
suggest that dysregulation of normal centrosome metabolism may be a transforming 
mechanism conserved by diverse tumor viruses.                
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METHODS 
Cells. Human Jurkat and JPX9 T lymphocytes and HTLV-I+ MT4 and C8166 cells were 
grown in RPMI 1640 medium containing 10% fetal bovine serum, glutamate and 
antibiotics. Human normal fetal lung fibroblasts IMR-90, human cervical carcinoma cell 
line HeLa, Chinese hamster ovary cell line CHO, African green monkey kidney cell line 
COS7 and rat embryonic fibroblasts REF were maintained in supplemented Dulbecco’s 
modified Eagle’s medium. IMR-90, HeLa, CHO and REF cells were transfected using 
LipofectAMINE 2000TM reagent (Invitrogen).  
 
Plasmids and antibodies. Full-length TAX1BP2 cDNA clone (KIAA0445) was kindly 
provided by Dr. Takahiro Nagase (Kazusa DNA Research Institute, Japan). cDNA for C-
Nap1 was a gift from Dr. Jerome Rattner (University of Calgary, Canada). Expression 
plasmid for γ-tubulin-GFP31 was supplied by Dr. Alexey Khodjakov (Wadsworth Center, 
New York, USA). cDNA for Nek2 was amplified from I.M.A.G.E. clone 3597227 
obtained from RZPD Deutsches Ressourcenzentrum für Genomforschung GmbH (Berlin, 
Germany). Expression vector pHA, pLTR-fLuc reporter plasmid, as well as expression 
plasmids for Tax, TaxM, Cdk2, MAD1 and MAD1M4 have been described 
elsewhere9,10,20. Expression vectors pFLAG-CMV2 and pEGFP were from Eastman 
Kodak and Clontech, respectively. Rb∆Cdk2 expression plasmid15 was a gift from Dr. 
Jiri Bartek (Institute of Cancer Biology, Denmark). Mouse monoclonal anti-γ-tubulin 
(clone GTU-88), rabbit polyclonal anti-γ-tubulin (T3559), mouse monoclonal anti-α-
tubulin (clone B-5-1-2), and mouse monoclonal anti-FLAG (clone M5) antibodies were 
from Sigma. Rabbit polyclonal anti-centrobin antibody14 was kindly provided by Dr. 
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Qingshen Gao (Northwestern University, Illinois, USA). Rabbit polyclonal anti-
pericentrin was from BAbCo-Covance. Mouse monoclonal anti-HA (clone F-7) and 
rabbit polyclonal anti-GFP (sc-8334) were from Santa-Cruz. Mouse monoclonal anti-Tax 
(clone 18A51-42) and rabbit polyclonal anti-Tax have been described elsewhere10,20. 
Polyclonal antiserum α-121a and α-121b were raised rabbits, against synthetic 
TAX1BP2 peptides LQAEKAEV AEALTKAEAGRVE LEL (amino acids 2-25) and 
TERTLEARERAHRQRVSTLKG (amino acids 1271-1291), respectively.  
 
Centrosome duplication assay. Centrosome duplication assay was performed in CHO 
cells as described15. Briefly, cells were seeded at low density and treated with 4 mM HU 
for 40 h. The number of centrosomes in 100-200 cells was analyzed by staining γ-tubulin. 
Transfected cells were identified by staining for the overexpressed protein or for GFP 
marker protein. Three to six independent experiments were usually performed for each 
transfection. 
 
Protein analysis and luciferase reporter assay. Co-immunoprecipitation, GST pull-
down, yeast two-hybrid analysis, Western blotting, and in vitro kinase assay with 
recombinant Cdk2 and Nek2 were performed as previously described10,20,32,33. Dual-
luciferase assay was carried out as per protocols recommended by Promega. 
 
Confocal microscopy. Jurkat, JPX9, MT4 and C8166 cells were adsorbed to poly-L-
lysine-coated coverslips, while HeLa and CHO cells were directly cultured on coverslips. 
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Cells were fixed with cold methanol or with 4% paraformaldehyde (pH 7.4) in PBS. The 
coverslips with attached cells were mounted on glass slides using VECTORSHIELD 
agent (VECTOR). Multi-color immunofluorescence imaging was then performed on a 
Zeiss LSM510 laser scanning confocal microscope. 
 
RNAi knockdown of TAX1BP2. The shRNA expression vector pSHAG-134 was a kind 
gift from Dr. Greg Hannon (Cold Spring Harbor Laboratory, New York, USA). The 
shRNA expression cassettes containing U6 promoter-sense-loop-antisense-termination 
signal T6 were amplified by PCR and inserted into the vector through TA cloning. To 
knockdown the expression of TAX1BP2, the expression vector for shRNA against 
TAX1BP2 (1 µg or 2 µg) was transfected into cells. Two shRNAs shBP2a and shBP2b, 
which target nucleotides 1776-1796 and 3236-3256, respectively, of the TAX1BP2 
mRNA transcript, were designed and used in the knockdown experiment. 
  
Focus formation assay and micronuclei formation assay. For focus formation 
assay35,36, REF cells were transfected with expression vectors for Tax and activated Ras 
(RasV12). The number of foci was scored after 21 days. Tax induction of micronuclei 
was measured in COS7 cells as previously described24. 
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FIGURE LEGENDS 
Figure 1 Centrosome amplification in HTLV-I-transformed and Tax-expressing cells. (a) 
Centrosome staining of Jurkat (Jkt) and MT4 cells. HTLV-I- Jurkat T lymphocytes and 
HTLV-I+ MT4 cells were loaded onto poly-L-lysine-coated coverslips and stained for γ-
tubulin. Bar, 30 µm. (b) Quantitation of cells with >2 centrosomes. Numbers of cells with 
>2 centrosomes were counted individually from 100 of Jurkat, MT4, C8166-45, 
uninduced JPX9, induced JPX9 (JPX9i), IMR-90, and Tax-expressing IMR-90 (IMR-
90x) cells. JPX9i cells were treated with 25 µm CdSO4 for 3 h to induce the expression of 
Tax. Some IMR-90x cells were co-transfected with an expression plasmid for γ-tubulin-
GFP. Centrosomes were either stained with anti-γ-tubulin (Sigma) or identified by γ-
tubulin-GFP fluorescence. Daughter centrioles in IMR-90x cells were stained with anti-
centrobin and a representative image of multiple daughter centrioles in one cell was 
shown in the inset. (c) Centrosome duplication assay in hydroxyurea (HU)-treated CHO 
cells. Cells were transfected with Rb∆Cdk (Rb∆) and Tax expression plasmids, 
respectively. Cells were treated with 4 mM HU for 40 h (except for group 1, which is the 
no HU control) and transfected cells (highlighted with arrow) were identified by staining 
for Tax or Rb. Centrosomes were stained with anti-γ-tubulin (Sigma). The inset on the 
top of panel 2 is a portion of the image shown at higher magnification which illustrates 
more clearly the amplified centrosomes in Tax-expressing cells. (d) Quantitative analysis 
of centrosome numbers in cells transfected with the variously indicated expression 
plasmids. (e) Centrosomal localization of Tax. HeLa cells were transfected with Tax 
expression plasmid and stained for Tax (panel 1) and pericentrin (panel 2). In panel 3, 
Green (representing Tax) and red (representing pericentrin) fluorescent signals were 
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overlaid. Colocalizations are shown in yellow. Arrows point to centrosome signals in 
transfected cells. (f) Tax association with γ-tubulin. Extracts of MT4 and Jurkat cells 
were immunoprecipitated with mouse IgG or mouse anti-γ-tubulin (α-γ-tub). The 
precipitates were then Western blotted with anti-Tax. An uncropped image of the blot is 
shown in Fig. S5. Results in b and d represent mean ± standard deviation from three 
independent experiments.  
 
Figure 2 Interaction between Tax and TAX1BP2. (a, b) Co-immunoprecipitation of Tax 
and TAX1BP2 from Tax-expressing cells. HeLa cells were transfected with a Tax 
expression plasmid. Reciprocal immunoprecipitation and Western blotting were 
performed with mouse anti-Tax (α-Tax) and rabbit anti-TAX1BP2 (α-BP2). (c) Tax-
binding domain in TAX1BP2. Interactions between TAX1BP2 mutants and Tax, as 
indicated by + (interaction) or – (lack of interaction), were analyzed by yeast two-hybrid 
assay. In mutants M5’ and M5’’, a leucine in the leucine zipper motif was replaced by a 
proline using site-directed mutagenesis. (d) GST pull-down assay. His-tagged Tax, GST, 
GST-TAX1BP2 (BP2) and GST-TAX1BP2-M5 (M5) proteins were produced in E. coli. 
His-Tax was then equilibrated individually with GST, GST-TAX1BP2 and GST-
TAX1BP2-M5 resins. Proteins bound to the resins were analyzed by Western blotting 
with anti-His antibodies. (e) Co-immunoprecipitation of Tax and TAX1BP2 from HTLV-
I-transformed MT4 cells. Immunoprecipitation and Western blotting were performed 
with extracts of MT4 cells as in b. (f) Colocalization of Tax and TAX1BP2. HeLa cells 
transfected with Tax expression plasmid and MT4 cells were stained for Tax (panels 1 
 
 
23
and 4) and TAX1BP2 (BP2; panels 2 and 5). Green (representing Tax) and red 
(representing TAX1BP2) fluorescent signals were then merged (panels 3 and 6) and 
colocalizations are in yellow (highlighted by arrows). The centrosomal staining pattern of 
Tax is representative of 61-74 % Tax-expressing cells. Colocalization of Tax with 
TAX1BP2 at the centrosomes was observed in 85% of cells exhibiting centrosome 
amplification. Bar, 30 µm. Uncropped images of the blots in d and e are presented in Fig. 
S5. 
 
Figure 3 TAX1BP2 is a centrosomal protein. (a) Colocalization of endogenous 
TAX1BP2 and γ-tubulin in HeLa cells. (b) Colocalization of overexpressed HA-tagged 
TAX1BP2 (HA-BP2) and γ-tubulin in HeLa cells. (c) Centrosomal localization of 
TAX1BP2-M6 in HeLa cells. (d) TAX1BP2-M7 is sufficient to target GFP to a 
microtubule-organizing center. HeLa cells were transfected with GFP-TAX1BP2-M7 and 
stained with anti-GFP (panel 1) and anti-α-tubulin (panel 2). (e) Microtubule-
independent localization of TAX1BP2 to the centrosome. HeLa cells transfected with an 
HA-TAX1BP2 expression plasmid were treated with 1ng/ml taxol for 16 h and stained 
for HA-TAX1BP2 (panel 1) and α-tubulin (panel 2). (f) Association of GFP-TAX1BP2-
M7 with γ-tubulin. HeLa cells were transfected with GFP-TAX1BP2-M7 expression 
plasmid (lane 2) and immunoblotted with anti-GFP and anti-γ-tubulin antibodies (lanes 1 
and 2). Extracts of transfected cells were immunoprecipitated (i.p.) with anti-GFP (α-
GFP) or rabbit IgG. The precipitates were then probed with anti-γ-tubulin (lanes 3-5). An 
uncropped image of the blot is presented in Fig. S5. 
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Figure 4 TAX1BP2 inhibits centrosome duplication. (a) Suppression of centrosome 
duplication by overexpression of TAX1BP2. CHO cells were transfected with indicated 
expression plasmids. Cells were treated with 4 mM HU for 40 h (except for group 1) and 
transfected cells (100 cells in each group) were quantitatively analyzed by staining for γ-
tubulin. Percentages of cells with >2 centrosomes were plotted. (b) Depletion of 
TAX1BP2 by RNAi. Two shRNAs targeting TAX1BP2 coding sequences were 
expressed from DNA vector pSHAG-1 in CHO cells expressing HA-tagged TAX1BP2. 
Two different doses of shRNA plasmid were used and the expression of HA-TAX1BP2 
and α-tubulin in transfected cells were examined by Western blotting. Uncropped images 
of the blots are shown in Fig. S5. (c) Centrosome duplication assay in TAX1BP2-
depleted cells. CHO cells were co-transfected with EGFP plasmid and shRNAs targeting 
TAX1BP2, treated with HU (except for group 1), and analyzed for centrosome 
duplication. shRNA-transfected cells were identified by GFP fluorescence. (d) 
Centrosome hyperamplification in TAX1BP2-depleted cells. CHO cells co-transfected 
with GFP plus TAX1BP2, Tax or TAX1BP2-depleting shRNAs were incubated for 72 h 
and the numbers of centrosomes were determined by γ-tubulin staining. shBP2-
expressing cells were also sorted out by GFP fluorescence and subjected to flow 
cytometric analysis of DNA content. Cells with 4N or >4N DNA content were not found 
upon depletion of TAX1BP2 (data not shown). Neither was cleavage failure found in 
TAX1BP2-depleted cells as stained with anti-α-tubulin. Results are representative of 
mean ± standard deviation from six independent experiments. 
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Figure 5 Tax induction of centrosome overduplication is through targeting of TAX1BP2. 
(a) Overexpression of TAX1BP2 counteracts the influence of Tax on centrosome 
duplication. CHO cells were transfected with indicated expression plasmids. Cells were 
treated with 4 mM HU for 40 h (except for group 1) and transfected cells (100 in each 
group) were quantified for > 2centrosomes. Fixed amount of Tax plasmid plus increasing 
amounts of TAX1BP2 plasmid (columns 5 and 6), fixed amount of TAX1BP2 plus 
increasing amounts of Tax (columns 7 and 8), and TAX1BP2 plus the highest dose of 
Tax mutant S132A (TaxM; column 9) were used for transfection. (b) Transcriptional 
activity of Tax mutant. CHO cells were co-transfected with luciferase reporter plasmid 
pLTR-fLuc under the control of HTLV-I LTR and expression plasmid for either Tax or 
TaxM. Dual luciferase assays were performed and the relative firefly luciferase activity 
was obtained by normalizing to the readouts of Renilla luciferase. (c) TaxM lacks the 
ability to bind TAX1BP2 and does not stimulate centrosome duplication. (d) TaxM does 
not induce focus formation in rat embryonic fibroblasts in cooperation with Ras. (e) 
TaxM does not induce the formation of micronuclei in COS7 cells. (f) TAX1BP2-M6 
lacks the ability to bind Tax and does not counteract Tax stimulation of centrosome 
duplication. Results represent mean ± standard deviation from six independent 
experiments. 
 
Figure S1 Expression of TAX1BP2 mRNA and protein in human tissues and cells. (a) 
Schematic diagrams of isoform-specific exons in TAX1BP2 and CROCC. Exons with 
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identical sequences are shown with the same color. (b, c) Northern blot analyses of 
human cancer cell lines and tissues. A TAX1BP2-specific probe was used and TAX1BP2 
transcripts are arrowed. (d) RT-PCR analyses of TAX1BP2 mRNA. A pair of TAX1BP2-
specific primers was used to detect TAX1BP2 mRNA in a group of human cancer cell 
lines. TAX1BP2 and β-actin transcripts are highlighted. (e) Western blot analysis of 
endogenous and overexpressed TAX1BP2 in HeLa cells. HeLa cells (lane 1) and HeLa 
cell transfected with TAX1BP2-expressing plasmid (lane 2; HeLa/BP2) were probed with 
anti-TAX1BP2 antiserum. TAX1BP2 protein of ~150kD is arrowed. 
 
Figure S2 Depletion of TAX1BP2 induces centrosome hyperamplification. CHO cells 
were co-transfected with GFP plus TAX1BP2-depleting shRNAs (shBP2a and shBP2b). 
Cells were incubated for 72 h and the numbers of centrosomes were determined by γ-
tubulin staining (panels 2, 5 and 8). Transfected cells were identified by GFP staining 
(panels 1, 4 and 7). Bar, 30 µm.  
 
Figure S3 Homodimerization of TAX1BP2. (a) Co-immunoprecipitation. HeLa cells 
were co-transfected with FLAG-tagged TAX1BP2 (fBP2) and HA-tagged TAX1BP2 
(haBP2) expression plasmids, and immunoblotted with anti-HA (upper panel). Extracts of 
transfected cells were immunoprecipitated with anti-HA. The precipitates were then 
probed with anti-FLAG (lower panel). (b) Mapping of dimerization domain in TAX1BP2. 
Interactions between TAX1BP2 mutants and TAX1BP2, as indicated by + (interaction) 
or – (lack of interaction), were analyzed by yeast two-hybrid assay. The dimerization 
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domain maps to amino acids 1137-1313, very close to the Tax-binding domain (amino 
acids 1109-1162, Fig. 2c). This raises the possibility that Tax might interfere with 
TAX1BP2 dimerization.  
 
Figure S4 Phosphorylation of TAX1BP2. (a) Phosphorylation by Nek2. HEK293T cells 
were transfected with expression plasmids for HA-TAX1BP2 and Myc-Nek2. The 
expression of TAX1BP2 and Nek2 was detected with anti-HA and anti-Myc. (b) Cdk2 
phosphorylation of TAX1BP2 in culture cells. TAX1BP2 and His-Cdk2 constructs were 
co-transfected into HEK293T cells and the lysates were probed with anti-HA and anti-
Cdk2 antibodies. Both His-Cdk2 and endogenous Cdk2 were detected. BP2* indicates a 
slow-migrating species corresponding to hyperphosphorylated TAX1BP2.  (c) In vitro 
phosphorylation of TAX1BP2 by Cdk2. Bacterially produced His-BP2 was incubated 
with one or two doses of reconstituted Cdk2/cyclin A complex in the presence of [γ32] 
ATP. The autoradiograph shows the phosphorylation of TAX1BP2 by Cdk2 and histone 
H1 was included as a control for Cdk2 activity. The TAX1BP2 band is more evident in a 
longer exposure shown in the lower panel.          
 
Figure S5 Full scan of Western blots. 
 
 





